PUNE, India, November 25, 2016 /PRNewswire/ --
According to a new market research report "Women's Health Diagnostics Market by application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021", published by MarketsandMarkets, The global Women's Health Diagnostics Market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.
Browse 265 market data tables and 37 figures spread through 292 pages and in-depth TOC on "Women's Health Diagnostics Market"
Early buyers will receive 10% customization on this report.
The global women health diagnostics market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented nine segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end users, the women health diagnostics market is segmented into hospital & clinics, home healthcare, and diagnostic & imaging centers.
In 2015, the breast cancer segment accounted for the largest share of the women health diagnostics market. The large share of the breast cancer segment is attributed to the high prevalence of breast cancer across the world, increasing number of women opting for routine breast check-up, and rising awareness about advanced breast cancer diagnostic techniques.
Make an Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=128928901
The end user segment in this market is divided into hospitals & clinics, imaging & diagnostic centers and home care. In 2015, the hospitals and clinics segment accounted for the largest share of the global Women's Health Diagnostics Market. The large share of this segment can be attributed to the fact that a greater proportion of patients (women) go to hospitals for the diagnosis/treatment of their health issues.
In 2015, North America accounted for the largest regional market, followed by Europe, Asia-Pacific, and the RoW. Asia-Pacific represents the fastest-growing region for the women health diagnostics market, primarily due to significant expansion and modernization of healthcare infrastructure, increasing per-capita income, and increasing focus of international device manufacturers on strengthening their distribution networks in this region. Moreover, the growing population in countries like China and India, epidemiological shift from infectious diseases to chronic diseases in this region are driving the growth of the Women's Health Diagnostics Market in APAC.
Major players in the global Women's Health Diagnostics Market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).
Browse Related Reports:
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020.
In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp
701 Pike Street
Suite 2175, Seattle
WA 98101, United States
Telephone No: 1-888-600-6441
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Last updated on: 25/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.